A RANDOMISED CONTROLLED TRIAL OF LOW-DOSE KETAMINE IN YOUTH WITH SEVERE DEPRESSION AND ELEVATED SUICIDE RISK

Grant number: 1138736 | Funding period: 2018 - 2022

Active

Abstract

Recent research has shown that a single injection of low-dose ketamine has powerful, though short-lived, antidepressant effects. Effective treatments are urgently needed for young people with severe depression. This will be the first controlled study to test whether repeated doses of ketamine, given over 4 weeks, is effective for young patients.